产品编号：L320107
产品规格：2.5mg
产品价格：面议
| 标准品编号: | L320107 |
| 名称: | Ledipasvir Impurity C |
| 别名: | Methyl ((S)-1-((1R,3S,4S)-3-(6-(9,9-difluoro-7-(2-((S)-5-((S)-3-methyl-2-((methylcarbamoyl)oxy)butanoyl)-5-azaspiro[2.4]heptan-6-yl)-1H-imidazol-5-yl)-9H-fluoren-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptan-2-yl)-3-methyl-1-oxobutan-2-yl)carbamate; Methyl [(2S)-1-{(6S)-6-[5-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxy carbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-6-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate |
| 参考CAS号: | 1256388-51-8 |
| 分子式: | C₄₉H₅₄F₂N₈O₆ |
| 分子量: | 889 |
| 种类: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Ledipasvir Impurity C is an impurity of Ledipasvir, which is most commonly used in combination with sofosbuvir for treatment in chronic hepatitis C genotype 1 patients. It inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion. |
| 参考文献 | |
